TITLE

Prognostic value of CRM1 in pancreas cancer

AUTHOR(S)
Wei-yi Huang; Lu Yue; Wen-shen Qiu; Li-wei Wang; Xiao-han Zhou; Yuan-jue Sun
PUB. DATE
December 2009
SOURCE
Clinical & Investigative Medicine;Dec2009, Vol. 32 Issue 6, pE315
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: Pancreatic cancer is a highly aggressive malignant tumour with poor prognosis. The median survival is only 6 months. This study investigated the prognostic value of nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 (CRM1) expression in pancreas cancer. Methods: CRM1 expression was detected, by Western blot, in pancreatic tissue from 69 cancer patients and 10 normal subjects. Results: CRM1 showed increased expression in pancreatic cancer tissue (P = 0.007). The high expression of CRM1 was associated with increased serum levels of CEA (P = 0.002) and CA19-9 (P = 0.005). There was an association between CRM1 expression and tumour size (P = 0.01), lymphadenopathy (P = 0.004) and liver metastasis (P = 0.003). High CRM1 expression was not correlated with the other linicopathological parameters. High CRM1 expression was a prognostic indicator for progression-free survival (PFS) (P = 0.006) as well as overall survival (OS) (P = 0.001). Expression of CRM1 was an independent prognostic parameter for poorer PFS and OS (95% CI, 1.27-5.39). Conclusions: CRM1 expression demonstrated prognostic value in pancreatic cancer. Prospective studies are required to determine the prognostic role of high expression of CRM1 in pancreatic cancer.
ACCESSION #
47781878

 

Related Articles

  • Immunohistochemical Study of Pancreatic Cystadenocarcinoma. Motojima, Koichi; Tomioka, Tsutomo; Tsunoda, Tsukasa; Kanamatsu, Takashi // American Journal of Gastroenterology;Jan1992, Vol. 87 Issue 1, p43 

    Seven cases of pancreatic cystadenocarcinoma were studied clinicopathologically and immunohistochemicalty. Four patients died of the disease or recurrence with metastasis to the liver and peritoneum within 2 yr after surgery. The remaining three patients are well after surgery. To distinguish...

  • Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer. Panni, Roheena; Sanford, Dominic; Belt, Brian; Mitchem, Jonathan; Worley, Lori; Goetz, Brian; Mukherjee, Pinku; Wang-Gillam, Andrea; Link, Daniel; DeNardo, David; Goedegebuure, S.; Linehan, David // Cancer Immunology, Immunotherapy;May2014, Vol. 63 Issue 5, p513 

    Pancreatic cancer (PC) mobilizes myeloid cells from the bone marrow to the tumor where they promote tumor growth and proliferation. Cancer stem cells (CSCs) are a population of tumor cells that are responsible for tumor initiation. Aldehyde dehydrogenase-1 activity in PC identifies CSCs, and its...

  • CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients. Zhonghu Li; Kai Chen; Peng Jiang; Xi Zhang; Xiaowu Li; Zhihua Li // Diagnostic Pathology;2014, Vol. 9 Issue 1, p1 

    Background and purpose: CD44 variants have been associated with tumor invasion and metastasis, but CD44 expression patterns have not been systematically investigated in pancreatic carcinoma. This study systematically investigated whether CD44 expression patterns are involved in pancreatic...

  • Rationalisation of cancer therapy: modelling the physical and immunological tumour microenvironment. Kok-Ho Ho // Australian Medical Student Journal;Jul2013, Vol. 4 Issue 1, p21 

    The tumour microenvironment has emerged as an important field in carcinogenesis. For most of the 20th century, cancer therapies have focused predominantly on tumour cells. Despite our best efforts, these therapies remain ineffective against cancers with poor prognosis such as ovarian and...

  • Inhibitory effect of cucurbitacin E on pancreatic cancer cells growth via STAT3 signaling. Chunyan Sun; Meixia Zhang; Xiaolei Shan; Xueying Zhou; Jiao Yang; Yanli Wang; Jesse Li-Ling; Yihui Deng // Journal of Cancer Research & Clinical Oncology;Apr2010, Vol. 136 Issue 4, p603 

    Pancreatic cancer has been a serious disease worldwide for its high mortality. Cucurbitacin E is a member of triterpenoid family isolated from plants showing antiproliferative activity on various cancer cells. In this study, we have explored whether cucurbitacin E also has an anti-tumor effect...

  • Stromal Metalloproteinase-9 Is Essential to Angiogenesis and Progressive Growth of Orthotopic Human Pancreatic Cancer in Parabiont Nude Mice. Nakamura, Toru; Kuwai, Toshio; Kim, Jang-Seong; Fan, Dominic; Kim, Sun-Jin; Fidler, Isaiah J. // Neoplasia;Nov2007, Vol. 9 Issue 11, p979 

    We determined whether host matrix metalloproteinase (MMP) 9 is essential to angiogenesis and to the growth of L3.6pl human pancreatic cancer cells implanted into the pancreas of wild-type (MMP-9+/+) and knockout (MMP-9-/-) nude mice. Four weeks after tumor cell injection, pancreatic tumors in...

  • Hypoxia Induced Tumor Metabolic Switch Contributes to Pancreatic Cancer Aggressiveness. Vasseur, Sophie; Tomasini, Richard; Tournaire, Roselyne; Iovanna, Juan L. // Cancers;2010, Vol. 2 Issue 4, p2138 

    Pancreatic ductal adenocarcinoma remains one of the most lethal of all solid tumors with an overall five-year survival rate of only 3-5%. Its aggressive biology and resistance to conventional and targeted therapeutic agents lead to a typical clinical presentation of incurable disease once...

  • FoxM1 is a Novel Target of a Natural Agent in Pancreatic Cancer. Zhiwei Wang; Ahmad, Aamir; Banerjee, Sanjeev; Azmi, Asfar; Dejuan Kong; Yiwei Li; Sarkar, Fazlul H. // Pharmaceutical Research;Jun2010, Vol. 27 Issue 6, p1159 

    Pancreatic cancer remains the fourth most common cause of cancer-related death in the United States. Therefore, novel strategies for the prevention and/or treatment are urgently needed. Genistein has been found to be responsible for lowering the rate of pancreatic cancer. However, the molecular...

  • Hepatic arterial infusion chemotherapy with gemcitabine and 5-fluorouracil or oral S-1 improves the prognosis of patients with postoperative liver metastases from pancreatic cancer. HIDEHIRO TAJIMA; HIROHISA KITAGAWA; TOMOYA TSUKADA; KOICHI OKAMOTO; SHIN-ICHI NAKANUMA; SEISHO SAKAI; ISAMU MAKINO; HIROYUKI FURUKAWA; HIRONORI HAYASHI; KATSUNOBU OYAMA; MASAFUMI INOKUCHI; HISATOSHI NAKAGAWARA; TOMOHARU MIYASHITA; HIROSHI ITOH; HIDETO FUJITA; HIROYUKI TAKAMURA; ITASU NINOMIYA; SACHIO FUSHIDA; TAKASHI FUJIMURA; TETSUO OHTA // Molecular & Clinical Oncology;2013, Vol. 1 Issue 5, p869 

    Hepatic metastasis is a common cause of treatment failure following resection of pancreatic cancer. In this study, we report our results of hepatic arterial infusion (HAI) chemotherapy with gemcitabine (GEM) plus 5-fluorouracil (5-FU) or oral S-1 treatment for postoperative liver metastases from...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics